Durable left ventricular assist device therapy in advanced heart failure: Patient selection and clinical outcomes

The increasing adoption of left ventricular assist devices (LVADs) into clinical practice is related to a combination of engineering advances in pump technology and improvements in understanding the appropriate clinical use of these devices in the management of patients with advanced heart failure....

Full description

Bibliographic Details
Main Authors: Sachin P. Shah, Mandeep R. Mehra
Format: Article
Language:English
Published: Elsevier 2016-04-01
Series:Indian Heart Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0019483216000468
_version_ 1818999497845374976
author Sachin P. Shah
Mandeep R. Mehra
author_facet Sachin P. Shah
Mandeep R. Mehra
author_sort Sachin P. Shah
collection DOAJ
description The increasing adoption of left ventricular assist devices (LVADs) into clinical practice is related to a combination of engineering advances in pump technology and improvements in understanding the appropriate clinical use of these devices in the management of patients with advanced heart failure. This review intends to assist the clinician in identifying candidates for LVAD implantation, to examine long-term outcomes and provide an overview of the common complications related to use of these devices.
first_indexed 2024-12-20T22:18:22Z
format Article
id doaj.art-d528a6791804453bb10222adfd698eec
institution Directory Open Access Journal
issn 0019-4832
language English
last_indexed 2024-12-20T22:18:22Z
publishDate 2016-04-01
publisher Elsevier
record_format Article
series Indian Heart Journal
spelling doaj.art-d528a6791804453bb10222adfd698eec2022-12-21T19:25:00ZengElsevierIndian Heart Journal0019-48322016-04-0168S1S45S5110.1016/j.ihj.2016.01.017Durable left ventricular assist device therapy in advanced heart failure: Patient selection and clinical outcomesSachin P. Shah0Mandeep R. Mehra1Center for Advanced Heart Disease, Brigham and Women's Hospital Heart and Vascular Center, Boston, MA, United StatesCenter for Advanced Heart Disease, Brigham and Women's Hospital Heart and Vascular Center, Boston, MA, United StatesThe increasing adoption of left ventricular assist devices (LVADs) into clinical practice is related to a combination of engineering advances in pump technology and improvements in understanding the appropriate clinical use of these devices in the management of patients with advanced heart failure. This review intends to assist the clinician in identifying candidates for LVAD implantation, to examine long-term outcomes and provide an overview of the common complications related to use of these devices.http://www.sciencedirect.com/science/article/pii/S0019483216000468HeartMate XVEREMATCHNovacor LVADINTERMACS
spellingShingle Sachin P. Shah
Mandeep R. Mehra
Durable left ventricular assist device therapy in advanced heart failure: Patient selection and clinical outcomes
Indian Heart Journal
HeartMate XVE
REMATCH
Novacor LVAD
INTERMACS
title Durable left ventricular assist device therapy in advanced heart failure: Patient selection and clinical outcomes
title_full Durable left ventricular assist device therapy in advanced heart failure: Patient selection and clinical outcomes
title_fullStr Durable left ventricular assist device therapy in advanced heart failure: Patient selection and clinical outcomes
title_full_unstemmed Durable left ventricular assist device therapy in advanced heart failure: Patient selection and clinical outcomes
title_short Durable left ventricular assist device therapy in advanced heart failure: Patient selection and clinical outcomes
title_sort durable left ventricular assist device therapy in advanced heart failure patient selection and clinical outcomes
topic HeartMate XVE
REMATCH
Novacor LVAD
INTERMACS
url http://www.sciencedirect.com/science/article/pii/S0019483216000468
work_keys_str_mv AT sachinpshah durableleftventricularassistdevicetherapyinadvancedheartfailurepatientselectionandclinicaloutcomes
AT mandeeprmehra durableleftventricularassistdevicetherapyinadvancedheartfailurepatientselectionandclinicaloutcomes